Catheter-Based Local Delivery of Therapeutics to the Lungs for Severe or Critically Ill Patients with COVID-19
Currently, the majority of treatment strategies reported for coronavirus disease (COVID-19) involve the systemic administration of drugs, in addition to other approaches including convalescent plasma.1,2 The pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was believed to...
Main Authors: | George Dangas, Christopher J. White, Nodar Kipshidze, Jawed Fareed, Patrick Iversen, Antonio Colombo, Nicholas Kipshidze |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2021-02-01
|
Series: | European Medical Journal Innovations |
Subjects: | |
Online Access: | https://www.emjreviews.com/innovations/article/catheter-based-local-delivery-of-therapeutics-to-the-lungs-for-severe-or-critically-ill-patients-with-covid-19/ |
Similar Items
-
Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients
by: Philipp K. Buehler, et al.
Published: (2021-04-01) -
Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection
by: Mousa Ahmad Alhiyari, et al.
Published: (2021-01-01) -
SARS-CoV-2 Infection with Different Radiological Insights
by: Barbara Brogna, et al.
Published: (2020-05-01) -
Covid-19 immune mechanisms: A systematic review
by: Shalini Gandhi, et al.
Published: (2020-01-01) -
Risk Factors for Reverse Transcriptase Polymerase Chain Reaction Positivity for SARS-CoV-2 among Healthcare Workers in a Group of Tertiary Care Hospitals in Mumbai: A Cross-sectional Study
by: Amit Shrenikraj Mutha, et al.
Published: (2021-04-01)